Araştırma özeti
Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by
IntroductionEarly differentiation between Parkinson's disease (PD) and multiple system atrophy-parkinsonian type (MSA-P) remains clinically challenging because of overlapping motor symptoms and subtle imaging abnormalities.MethodsWe developed a fully automated multimodal PET/MRI framework for early PD-MSA-P differentiation that integrates atlas-guided subject-specific label generation, nnU-Net segmentation of the caudate nuclei and putamina, multimodal image fusion, and Vision Transformer classification with multi-slice voting (ViT+MSV). A total of 155 early-stage patients, including 121 with PD and 34 with MSA-P, were evaluated using patient-level stratified 4-fold cross-validation.ResultsThe segmentation model achieved an overall Dice score of 0.853 (95% CI, 0.830-0.877) and an IoU of 0.747 (95% CI, 0.725-0.770). ViT+MSV achieved a cross-validated AUC of 0.947 (95% CI, 0.905-0.981), an accuracy of 0.929 (95% CI, 0.890-0.968), a sensitivity of 0.942 (95% CI, 0.900-0.982), and a specificity of 0.882 (95% CI, 0.765-0.974). The combination of [18F]fluorodeoxyglucose (FDG) PET, [11C]CFT dopamine-transporter PET, and T2-weighted imaging (T2WI) showed the best overall classification performance. Grad-CAM visualizations showed that class-discriminative gradient-based saliency was mainly concentrated on the bilateral putamen.DiscussionThese findings suggest that anatomically guided multimodal PET/MRI analysis with transformer-based classification may support early PD-MSA-P differentiation while providing spatially interpretable evidence for model decisions.
Bilimsel değerlendirme
Araştırma sorusu
Sorunun kapsamı orijinal çalışma üzerinden değerlendirilir.
Yöntem ve örneklem
Çalışma tasarımı ve örneklem için kaynak makaleyi kontrol edin.
Temel bulgular
Bu kayıt için editoryal olarak onaylanmış bulgu özeti henüz yayımlanmadı.
Sınırlılıklar
Sonuçların genellenebilirliği, yanlılık ve klinik anlamı ayrıca incelenmelidir.
Bibliyografik veriden yöntem, örneklem veya klinik sonuç çıkarımı yapılmaz.